Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
FibroBiologics, Inc. (FBLG)
NASDAQ:FBLG
RESEARCH TOOLSreports
FibroBiologics, Inc. (FBLG) Stock Price & Analysis
15 Followers
FBLG Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$6.53 - $55.00
Previous Close$11.35
Volume11.49K
Average Volume (3M)68.48K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$10.77M
Total Debt (Recent Filing)$1.80M
Price to Earnings (P/E)N/A
Beta-0.75
Next Earnings
May 14, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding32,719,125
10 Day Avg. Volume61,182
30 Day Avg. Volume68,478
Standard Deviation0.23
R-Squared0.55
Alpha-0.24
Financial Highlights & Ratios
Price to Book (P/B)35.24
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
FibroBiologics, Inc. News
PremiumPress Releases
FibroBiologics Files 2024 First Quarter Report
Ownership Overview
0.00%
Insiders
0.00% Mutual Funds
0.16% Other Institutional Investors
99.84% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
FBLG FAQ
What was FibroBiologics, Inc.’s price range in the past 12 months?
FibroBiologics, Inc. lowest stock price was $6.53 and its highest was $55.00 in the past 12 months.
What is FibroBiologics, Inc.’s market cap?
Currently, no data Available
When is FibroBiologics, Inc.’s upcoming earnings report date?
FibroBiologics, Inc.’s upcoming earnings report date is May 14, 2024 which is 6 days ago.
How were FibroBiologics, Inc.’s earnings last quarter?
Currently, no data Available
Is FibroBiologics, Inc. overvalued?
According to Wall Street analysts FibroBiologics, Inc.’s price is currently Overvalued.
Does FibroBiologics, Inc. pay dividends?
FibroBiologics, Inc. does not currently pay dividends.
What is FibroBiologics, Inc.’s EPS estimate?
FibroBiologics, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does FibroBiologics, Inc. have?
FibroBiologics, Inc. has 32,719,124 shares outstanding.
What happened to FibroBiologics, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of FibroBiologics, Inc.?
Currently, no hedge funds are holding shares in FBLG
---
FibroBiologics, Inc. Stock Smart Score
Company Description
FibroBiologics, Inc.
FibroBiologics, Inc. operates as a clinical-stage cell therapy company that focuses on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs. The company develops CybroCell for degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for treating wound healing. Its early-stage research programs include CYTER915 which is designed to regenerate or reinvigorate production of the thymus and/or spleen; and TCB190 for the treatment of cancers. The company was incorporated in 2021 and is based in Houston, Texas. FibroBiologics, Inc. operates as a subsidiary of Spinalcyte Llc.
---
Technical Analysis
---